435 related articles for article (PubMed ID: 37725102)
1. Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases.
Han YH; Liu XD; Jin MH; Sun HN; Kwon T
Inflamm Res; 2023 Sep; 72(9):1839-1859. PubMed ID: 37725102
[TBL] [Abstract][Full Text] [Related]
2. Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons.
Moonen S; Koper MJ; Van Schoor E; Schaeverbeke JM; Vandenberghe R; von Arnim CAF; Tousseyn T; De Strooper B; Thal DR
Acta Neuropathol; 2023 Feb; 145(2):175-195. PubMed ID: 36481964
[TBL] [Abstract][Full Text] [Related]
3. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.
Wang S; Yuan YH; Chen NH; Wang HB
Int Immunopharmacol; 2019 Feb; 67():458-464. PubMed ID: 30594776
[TBL] [Abstract][Full Text] [Related]
4. Total paeony glycoside relieves neuroinflammation to exert antidepressant effect via the interplay between NLRP3 inflammasome, pyroptosis and autophagy.
Su L; Lu H; Zhang D; Zhu X; Li J; Zong Y; Zhao Y; He Z; Chen W; Du R
Phytomedicine; 2024 Jun; 128():155519. PubMed ID: 38492365
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 inflammasome in neurodegenerative disease.
Anderson FL; Biggs KE; Rankin BE; Havrda MC
Transl Res; 2023 Feb; 252():21-33. PubMed ID: 35952982
[TBL] [Abstract][Full Text] [Related]
6. The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases.
Feng YS; Tan ZX; Wu LY; Dong F; Zhang F
Biomed Pharmacother; 2021 Jun; 138():111428. PubMed ID: 33667787
[TBL] [Abstract][Full Text] [Related]
7. ChemR23 activation attenuates cognitive impairment in chronic cerebral hypoperfusion by inhibiting NLRP3 inflammasome-induced neuronal pyroptosis.
Zhang Y; Zhang J; Zhao Y; Zhang Y; Liu L; Xu X; Wang X; Fu J
Cell Death Dis; 2023 Nov; 14(11):721. PubMed ID: 37932279
[TBL] [Abstract][Full Text] [Related]
8. NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective.
Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Jabir MS; Saad HM; Batiha GE
J Cell Mol Med; 2023 Jul; 27(13):1775-1789. PubMed ID: 37210624
[TBL] [Abstract][Full Text] [Related]
9. Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases.
Wu AG; Zhou XG; Qiao G; Yu L; Tang Y; Yan L; Qiu WQ; Pan R; Yu CL; Law BY; Qin DL; Wu JM
Ageing Res Rev; 2021 Jan; 65():101202. PubMed ID: 33161129
[TBL] [Abstract][Full Text] [Related]
10. Lipocalin-2-mediated astrocyte pyroptosis promotes neuroinflammatory injury via NLRP3 inflammasome activation in cerebral ischemia/reperfusion injury.
Li J; Xu P; Hong Y; Xie Y; Peng M; Sun R; Guo H; Zhang X; Zhu W; Wang J; Liu X
J Neuroinflammation; 2023 Jun; 20(1):148. PubMed ID: 37353794
[TBL] [Abstract][Full Text] [Related]
11. The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases.
Possemato E; La Barbera L; Nobili A; Krashia P; D'Amelio M
Ageing Res Rev; 2023 Jun; 87():101907. PubMed ID: 36893920
[TBL] [Abstract][Full Text] [Related]
12. Low-density lipoprotein receptor (LDLR) regulates NLRP3-mediated neuronal pyroptosis following cerebral ischemia/reperfusion injury.
Sun R; Peng M; Xu P; Huang F; Xie Y; Li J; Hong Y; Guo H; Liu Q; Zhu W
J Neuroinflammation; 2020 Nov; 17(1):330. PubMed ID: 33153475
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson's Disease.
Han QQ; Le W
Neurosci Bull; 2023 May; 39(5):832-844. PubMed ID: 36757612
[TBL] [Abstract][Full Text] [Related]
14. Activating cGAS-STING axis contributes to neuroinflammation in CVST mouse model and induces inflammasome activation and microglia pyroptosis.
Ding R; Li H; Liu Y; Ou W; Zhang X; Chai H; Huang X; Yang W; Wang Q
J Neuroinflammation; 2022 Jun; 19(1):137. PubMed ID: 35689216
[TBL] [Abstract][Full Text] [Related]
15. A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease.
Lee JH; Kim HJ; Kim JU; Yook TH; Kim KH; Lee JY; Yang G
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525754
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of NLRP3 activation and pathology during neurodegeneration.
Jose S; Groves NJ; Roper KE; Gordon R
Int J Biochem Cell Biol; 2022 Oct; 151():106273. PubMed ID: 35926782
[TBL] [Abstract][Full Text] [Related]
17. The involvement of NLRP3 inflammasome in the treatment of Alzheimer's disease.
Feng YS; Tan ZX; Wu LY; Dong F; Zhang F
Ageing Res Rev; 2020 Dec; 64():101192. PubMed ID: 33059089
[TBL] [Abstract][Full Text] [Related]
18. Pseudorabies virus infection activates the NLRP3 and IFI16 inflammasomes to trigger pyroptosis.
Zhang X; Chen G; Yin J; Li L; Huang K; Du Q; Tong D; Huang Y
Vet Microbiol; 2023 Sep; 284():109826. PubMed ID: 37421928
[TBL] [Abstract][Full Text] [Related]
19. Suppression of NLRP3 Inflammasome, Pyroptosis, and Cell Death by NIM811 in Rotenone-Exposed Cells as an in vitro Model of Parkinson's Disease.
Zhang M; He Q; Chen G; Li PA
Neurodegener Dis; 2020; 20(2-3):73-83. PubMed ID: 33176317
[TBL] [Abstract][Full Text] [Related]
20. Knowledge Mapping of Inflammasome and Pyroptosis in Stroke: A Bibliometric Analysis (2007-2023).
Wu M; Sun A; Jiang H; Zhang Y; Zhao Z; Zhu B
Clin Invest Med; 2023 Sep; 46(3):E19-33. PubMed ID: 37769275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
